The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,408.00
Bid: 1,403.00
Ask: 1,414.00
Change: 8.00 (0.57%)
Spread: 11.00 (0.784%)
Open: 1,400.00
High: 1,426.00
Low: 1,365.00
Prev. Close: 1,400.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Replacement Director/PDMR Shareholding

18 Mar 2024 17:14

RNS Number : 3043H
Indivior PLC
18 March 2024
 

INDIVIOR PLC (THE 'COMPANY')

CORRECTION - NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM

Correction made to the announcement made earlier today at 16:17:57 (RNS No 2961H) on 18 March 2024. The original announcement included an incorrect shareholding in respect of the number of shares held by Mr Crossley following completion of the transactions. Following these transactions, Mr Crossley holds 90,032 shares.

All other details regarding the transactions in the announcement remain unchanged.

The amended announcement is set out in full below:

The Company announces the following transactions carried out by Mark Crossley, a PDMR and the Chief Executive of the Company on March 14, 2024, and March 15, 2024.

On March 15, 2024, an award over 19,215 Ordinary Shares of $0.10 each ('Shares') vested in favour of Mark under the Indivior Deferred Bonus Plan 2018 (the 'DBP'). This award was granted on March 15, 2022 and vested following the end of the two-year deferral period. The vesting of the award was not subject to performance conditions. The vesting of this award was settled on a net-settled basis, resulting in the delivery of Shares in the amount set out below.

Name of PDMR

Number of vested Shares

Number of Shares delivered

Mark Crossley

19,215

10,549

 

On March 15, 2024, Mark also received 15,444 Shares, following the exercise and net settlement of a share option. The option exercise was in respect of an option over 42,123 Shares granted on December 29, 2014, at an option price of £5.55 per share.

On March 14, 2024, March 15, 2024 and March 18, 2024, Mark Crossley disposed of a total of 117,197 Shares; 25,993 Shares arising from the above transactions and 91,204 Shares from the release of vested awards under the Indivior Long-Term Incentive Plan on March 5, 2024.

91,204 Shares were sold on March 14, 2024 at an average price of £16.30 per share. 15,444 Shares were sold on March 15, 2024 at an average price of £16.44 per share and 10,549 Shares were sold on March 18, 2024 at an average price of £16.17 per share. 

 

Following the completion of these transactions, Mark Crossley has an interest in 90,032 Shares in the Company.

 

This notification is made in accordance with the requirements of the UK Market Abuse Regulation.

Kathryn Hudson

Company Secretary

Company Secretary

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Mark Crossley

2

 

Reason for the notification

 

a)

 

Position/status

  

Director / PDMR - Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Indivior PLC

b)

 

LEI

213800V3NCQTY7IED471

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of US$0.50

 

 

GB00BN4HT335

b)

 

Nature of the transaction

Delivery of Shares on Vesting of an award granted under the DBP.

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

N/A

10,549

d)

 

Aggregated information

 

- Aggregated volume

- Price

 

 

N/A

e)

 

Date of the transaction

March 15, 2024

f)

 

Place of the transaction

 

Outside a trading venue

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of US$0.50

 

 

GB00BN4HT335

b)

 

Nature of the transaction

Delivery of Shares arising from exercise of an option

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£5.55

15,444

d)

 

Aggregated information

 

- Aggregated volume

- Price

 

 

N/A

e)

 

Date of the transaction

March 15, 2024

f)

 

Place of the transaction

 

Outside a trading venue

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of US$0.50

 

 

GB00BN4HT335

b)

 

Nature of the transaction

Sale of Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£16.30

91,204

d)

 

Aggregated information

 

- Aggregated volume

- Price

 

 

N/A

e)

 

Date of the transaction

March 14, 2024

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of US$0.50

 

 

GB00BN4HT335

b)

 

Nature of the transaction

Sale of Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£16.44

15,444

d)

 

Aggregated information

 

- Aggregated volume

- Price

 

 

N/A

e)

 

Date of the transaction

March 15, 2024

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of US$0.50

 

 

GB00BN4HT335

b)

 

Nature of the transaction

Sale of Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£16.17

10,549

d)

 

Aggregated information

 

- Aggregated volume

- Price

 

 

N/A

e)

 

Date of the transaction

March 18, 2024

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHJPMRTMTMBBPI
Date   Source Headline
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNS1st Quarter Results
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20243:23 pmRNSHolding(s) in Company
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20242:53 pmRNSNotice of Results
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20249:02 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20242:07 pmRNSPublication of Notice of Annual General Meeting
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20244:00 pmRNSHolding(s) in Company
21st Mar 20242:30 pmRNSAppointment of Independent Non-Executive Director
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20245:14 pmRNSReplacement Director/PDMR Shareholding
18th Mar 20244:21 pmRNSDirector/PDMR Shareholding
18th Mar 20244:17 pmRNSDirector/PDMR Shareholding
18th Mar 20242:00 pmRNSDirector/PDMR Shareholding
18th Mar 202410:45 amRNSHolding(s) in Company
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20244:47 pmRNSDirector/PDMR Shareholding
15th Mar 20244:40 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20244:06 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20242:00 pmRNSDirector/PDMR Shareholding
13th Mar 20241:09 pmRNSAnnual Financial Report
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20243:33 pmRNSHolding(s) in Company
12th Mar 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.